Publications by authors named "Greg Markey"

Claim this Profile
T
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.
Sahra Ali, Rune Kjeken, Christiane Niederlaender, Greg Markey, Therese S Saunders

Oncologist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
Kyriaki Tzogani, Beatriz Florez, Greg Markey, Mariapaola Caleno, Odoardo Maria Olimpieri

ESMO Open· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use.
Marta Kollb-Sielecka, Pierre Demolis, Joseph Emmerich, Greg Markey, Tomas Salmonson

Sleep Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene.
Manuel Haas, Viktor Vlcek, Pavel Balabanov, Tomas Salmonson, Serge Bakchine, Greg Markey

Neuromuscul Disord· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis